MKI67 and neoplasm: The differences included the smaller tumor size (and more frequent microcarcinomas), more frequent oncocytic changes and multifocality, higher Ki67 LI, more frequent dominant papillary and less frequent follicular growth patterns, less frequent lymphatic/vascular invasion, extrathyroidal extension, regional and distant metastasis in the BRAFV600E-positive PTCs.